CERT
Certara, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$9.45
+0.85%Year over year
Reported trailing growth
- Revenue
- +0.7%
- EBITDA
- +32.6%
- EBIT
- -70.5%
- EPS
- —
- Free cash flow
- -25.6%
- Operating cash flow
- -18.4%
Forward estimates
Based on analyst estimates
- Revenue
- -5.9%
- EBITDA
- +76.7%
- EPS
- +188.7%
Three-year CAGR
- Revenue
- +7.7%
- EBITDA
- +4.8%
- EBIT
- -13.5%
- Net income
- +86.8%
- EPS
- +86.7%
- Free cash flow
- -4.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026